BioMarin Pharmaceutical’s strong rare disease drug portfolio and Amicus acquisition drive a ‘Buy’ rating. Click here to read my latest analysis of BMRN stock.
Netflix, Inc. acquires Warner Bros. Discovery, Inc. for $82.7B, eyeing $2–3B cost savings and global growth. Click for more ...
GGL options up to 90% of the vein system at its Gold Point ProjectInitial cash payment of US$190,000Retained upside via staged share payments, a 2% NSR and future Performance RightsTeck terminates ...
VWAP, or volume-weighted average price, is a technical analysis tool used primarily on intraday charts. It provides a benchmark for the average price a security has traded at during the day, taking ...
CLAIRE, Quebec, December 15, 2025--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) and ...
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, RELEASED, OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, BELARUS, ...
This article was written by Bloomberg Intelligence Market Structure Research Strategist Nicholas Phillips. It appeared first on the Bloomberg Terminal. Buyside firms are accelerating order and ...
After the White House used a Sabrina Carpenter song without her permission, the pop star is keeping her response short and sweet. The "Espresso" singer, 26, took to X to slam the White House for using ...
Discover how Apple Inc. and Carnegie Steel Co. leveraged backward integration to control supply chains and enhance efficiency ...
This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All ...
Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results